Parameters | The entire cohort of patients (n = 20, 100%) | Patients still alive at the end of follow-up (n = 15; 75%) | Deceased patients at the end of follow-up (n = 5; 25%) |
---|---|---|---|
0.81 (0.62–1.07) | 0.76 (0.62–0.91) | 0.96 (0.76–1.07) | |
0.48 (0.13–0.79) | 0.57 (0.23–0.79) | 0.22 (0.13–0.35) | |
0.32 (0.15–0.64) | 0.32 (0.17–0.64) | 0.22 (0.15–0.37) | |
0.17 (0.06–0.43) | 0.15 (0.07–0.43) | 0.35 (0.06–0.41) | |
10.5 (2.6–54.9 ). | 8.8 (2.6–44.55) | 18.21 (6.6–54.9) | |
ΔADC | 22.5% (1.7 to 52.4%) | 25.0 (4.7 to 51.4) | 9.2 (1.7 to 52.4) |
ΔKtrans | -50.3% (-93.4 to 179.2%) | -60.0 (-93.0 to -43.2) | 4.2 (-37.1 to 179.2) |
ΔVe | -35.2% (-88.9 to 126.8%) | -40.0 (-88.9 to 65.4) | -14.7 (-40. to 126.8) |
ΔVp | 70% (73.2 to 357.14%) | 92.9 (-18.6 to 357.2) | 10.0 (-73.2 to 100) |
ΔTumour volume | (-15.0%; -76.3 to 254.6%); | -14.0 (-76.3 to 254.6) | -19.6 (-37.7 to 114.72) |
Patient | Sex | Age (yrs) | Tumour location | TNM | Stage |
---|---|---|---|---|---|
1 | M | 53 | Oropharynx | T4aN1 | IVA |
2 | M | 67 | Hypopharynx | T3N1 | III |
3 | M | 66 | Hypopharynx | T3N2b | IVA |
4 | M | 56 | Oropharynx | T3N2b | IVA |
5 | M | 49 | Oropharynx | T2N2b | IVA |
6 | M | 57 | Oropharynx | T4aN2c | IVA |
7 | M | 59 | Hypopharynx | T4aN2b | IVA |
8 | M | 60 | Oropharynx | T3N2b | IVA |
9 | M | 58 | Oropharynx | T4aN2b | IVA |
10 | M | 53 | Oropharynx | T4aN2c | IVA |
11 | M | 64 | Oropharynx | T3N2c | IVA |
12 | M | 56 | Hypopharynx | T3N2b | IVA |
13 | M | 65 | Oropharynx | T2N2b | IVA |
14 | M | 53 | Hypopharynx | T4aN2c | IVA |
15 | M | 66 | Oropharynx | T3N2b | IVA |
16 | M | 65 | Oropharynx | T3N2a | IVA |
17 | M | 46 | Oropharynx | T3N3 | IVB |
18 | M | 67 | Hypopharynx | T3N1 | III |
19 | F | 58 | Oropharynx | T3N1 | III |
20 | M | 48 | Hypopharynx | T3N1 | III |
Parameters | Disease-free survival (p value) | Overall survival (p value) |
---|---|---|
Age | 0.338 | 0.556 |
Tumour location | 0.396 | 0.752 |
Stage | 1.000 | 0.198 |
ADC (x 10-3 mm |
0.856 | 0.012* |
Ktrans (min-1) | 0.116 | 0.026* |
Ve | 0.754 | 0.293 |
Vp | 0.165 | 0.342 |
Tumour volume | 0.959 | 0.048* |
ΔADC (%) | 0.740 | 0.061 |
ΔKtrans | 0.688 | 0.014* |
ΔVe | 0.957 | 0.405 |
ΔVp | 0.672 | 0.077 |
ΔTumour volume (ml) | 0.495 | 0.486 |